ARTES Biotechnology GmbH
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
CDMO for microbial cell line and process development based on yeast and bacteria
Globally working, well established and a reliable technology provider for recombinant protein production. Development for the target of choice: that can be a vaccine, a biopharmaceutical, a biosimilar and/or enzyme. ARTES has also a broad spectrum of ready-to-transfer processes for enzymes, vaccines and biosimilars.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}